계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
Eyenovia
About
Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.
- New York,New York,United States
- 51 - 100
- https://eyenovia.com/
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Stock Symbol
- nasdaq:EYEN
- Legal Name
- Eyenovia, Inc.
Eyenovia is a biopharmaceutical company that provides portfolio of next generation topical eye treatments. It is a clinical stage, ophthalmic biopharmaceutical company that transforms the delivery of therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others.Eyenovia’s breakthrough piezo-dispersion and microdosing technology enable a portfolio of first-in-class, next-generation, micro-therapeutics for the eye designed to reduce ocular and systemic toxicity and improve the risk-benefit profile of both new and existing therapeutics.Eyenovia was founded in 2014.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 22, 2022 | Post-IPO Debt | $10M | 1 |
|
— | Detail |
| Mar 4, 2022 | Post-IPO Equity | $15M | 1 |
|
— | Detail |
| May 10, 2021 | Post-IPO Debt | $25M | 1 |
Silicon Valley Bank
|
— | Detail |
| Mar 23, 2020 | Post-IPO Equity | $6M | — | — | — | Detail |
| Jan 4, 2019 | Post-IPO Equity | $3.10M | — | — | — | Detail |
Investments
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Debt |
|
|
Yes | Post-IPO Equity |
|
Silicon Valley Bank
|
Yes | Post-IPO Debt |
Employee Profiles
